Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2007
11/29/2007US20070274933 Amino- and hydroxysubstituted triphenyl-S-triazines as stabilizers
11/29/2007US20070274909 Radiation Therapy and Medical Imaging Using Uv Emitting Nanoparticles
11/29/2007DE68907430C5 Cytotoxische Therapie. Cytotoxic therapy.
11/29/2007DE20023915U1 Oxidativ stabile langkettige Ethylester-Weichmacher Oxidatively stable long-chain ethyl ester plasticizer
11/29/2007DE102006024528A1 Neue, an der Tumorphysiologie orientierte Formulierung eines Zytostatikums, insbesondere von cis-Platin Last, based on the formulation of a cytostatic tumor physiology, in particular cis-platinum
11/29/2007CA2752585A1 Delivery of active agents using a chocolate vehicle
11/29/2007CA2752530A1 Delivery of active agents using a chocolate vehicle
11/29/2007CA2752522A1 Delivery of active agents using a chocolate vehicle
11/29/2007CA2652967A1 Hydrogels of polysaccharide mixtures for tissue engineering and as carriers of active compounds
11/29/2007CA2652656A1 High-molecular weight conjugate of podophyllotoxins
11/29/2007CA2651500A1 Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds
11/28/2007EP1860118A2 Immunoadhesin comprising a glycoprotein VI domain
11/28/2007EP1859812A1 Polycation chargeable polymer and use as carrier of nucleic acid
11/28/2007EP1859811A1 Use of conjugates of amatoxins or phallotoxins with macromolecules for tumor and inflammation therapy
11/28/2007EP1859810A1 Peg-modified arginine/lysineoxidoreductase
11/28/2007EP1859809A1 Composition for dry conservation of microorganisms
11/28/2007EP1859791A1 Sugar-coated pill
11/28/2007EP1859790A2 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
11/28/2007EP1859264A1 Method for analyzing activated polyethylene glycol compounds
11/28/2007EP1859041A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
11/28/2007EP1858556A1 Vehicle for topical delivery of anti-inflammatory compounds
11/28/2007EP1858555A2 Fucoidan compositions and methods for dietary and nutritional supplements
11/28/2007EP1858541A2 Use of modulators of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism
11/28/2007EP1858503A1 Topical gels compositions
11/28/2007EP1858494A2 New soft gelatin capsules
11/28/2007EP1858488A1 Tigecycline compositions and methods of preparation
11/28/2007EP1858484A1 Microemulsions of cannabinoid receptor binding compounds
11/28/2007EP1765356B1 Spray composition comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non volatile oily phase
11/28/2007EP1592447B1 Devices and compositions containing boron and silicon for use in neutron capture therapy
11/28/2007EP1560571A4 Edible film for relief of cough or symptoms associated with pharyngitis
11/28/2007EP1553909A4 Quick dissolve compositions and tablets based thereon
11/28/2007EP1545620B1 Pharmaceutical compositions comprising cyclosporin for oral administration
11/28/2007EP1480691A4 Agglomerated particles for aerosol drug delivery
11/28/2007EP1328245B1 Dental care compositions
11/28/2007EP1206290B1 Cyclodextrin containing pressure sensitive adhesives
11/28/2007CN200980747Y Medicine releasing structure for medicine eluting apparatus
11/28/2007CN101080499A Genomic screen for epigenetically silenced tumor suppressor genes
11/28/2007CN101080426A Use of amphiphilic copolymers as solubilising agents
11/28/2007CN101080384A Manufacture process of N-substituted salicylamide
11/28/2007CN101080247A Biomaterials carrying cyclodextrines having improved absorption properties and used for the progressive and delayed release of therapeutic molecules
11/28/2007CN101080246A Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
11/28/2007CN101080244A Medical tape preparation
11/28/2007CN101080222A Chemically stable compositions of 4-hydroxy tamoxifen
11/28/2007CN101077888A Polyethylene glycol modified neurotoxin, preparation method and use thereof
11/28/2007CN101077418A Bacteria nano magnetosome loaded with primary amino medicine and preparation method thereof
11/28/2007CN101077417A Magnetic target medicine sustained and controlled release carrier material and preparation method and application thereof
11/28/2007CN101077415A Water-bome suction-type medicinal composition
11/28/2007CN101077355A Double effects natural clarificant and using technology thereof
11/28/2007CN101077352A Eye preparation containing lactose-azithromycin
11/28/2007CN101077351A Soft capsules containing roxithromycin
11/28/2007CN101077350A Compostion and method of treating gonad dysfunction
11/28/2007CN101077349A Total alkaloids of subprostrate sophora root soft capsules and preparation method and application thereof
11/28/2007CN101077348A Amoxicillin-clavulantes sustained release tablets
11/28/2007CN101077347A Multifunctional membrane used for glaucoma post-operation and preparation method thereof
11/28/2007CN101077344A Infusion preparation of ibuprofen and preparation method thereof
11/28/2007CN101077343A Dexibuprofen granule and preparation method thereof
11/28/2007CN101077342A Method for formulating nutrition replenisher special-purpose used for children amblyopia
11/28/2007CN101077340A Penetration-promoting type catablasm matrix and preparation method thereof
11/28/2007CN101077339A Dexibuprofen effervescent tablet and preparation method thereof
11/28/2007CN101077337A Vitamin injection used for promoting female animal estrus and Increasing breeding and preparation method thereof
11/28/2007CN101077336A Injection containing ketoprofen and preparation method thereof
11/28/2007CN101077335A Anticancer composition containing tyrosine kinase inhibitor
11/28/2007CN101077334A Anticancer composition containing tyrosine kinase inhibitor
11/28/2007CN100351255C Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/28/2007CN100350981C Radioactive therapeutic Liposomes
11/28/2007CN100350978C Medicine-carried degradable type lacrimal duct embolus, and its prepn. method
11/28/2007CN100350977C Medicinal compositions
11/28/2007CN100350976C Reversible gelling system for ocular drug delivery
11/28/2007CN100350971C Stimulation of bone growth with thrombin peptide derivatives
11/28/2007CN100350913C Colonic release composition
11/28/2007CN100350912C Nanometer partical administration system of prostaglandin E1 coated with polyglycol derived phospholipid
11/28/2007CN100350911C Pharmaceutical compsn. comprising poorly water-soluble active ingredient, surfactant and water-soluble polymer
11/27/2007US7300990 A block copolymer of the A-B or A-B-A type in which A and B are different in which at least one of the A and B is formed from ethylenically unsaturated monomer including a zwitterionic monomer; is 2-methacryloyloxyethyl-2'-trimethylammonium ethyl phosphate inner salt as a monomer; for drug delivery
11/27/2007US7300924 Conjugate of rifampicin linked to one or more phosphonate groups; allows accumulation or retention inside cells; improved anti-infective activity and pharmacokinetic properties, including oral bioavailability, greater potency and half-life in vivo
11/27/2007US7300669 Fatty alcohol, skin conditioner, propylene glycol, mineral oil or white soft paraffin and water; fluticasone propionate and oil in water emulsion includig excipients; antiinflammatory agents
11/27/2007US7300668 System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
11/27/2007US7300666 Mixture for transdermal delivery of low and high molecular weight compounds
11/27/2007US7300665 Nocturnal muscle enhancing composition and method
11/27/2007US7300664 Vaginally administrable progesterone-containing tablets and method for preparing same
11/27/2007US7300662 Local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography, lower systemic toxicity
11/27/2007US7300655 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/27/2007US7300644 Targeted combination immunotherapy
11/27/2007US7300412 Methods for therapeutic treatment of carpal tunnel syndrome
11/27/2007CA2391333C Sustained release formulation of a peptide and a copolymer
11/27/2007CA2338896C Fast dissolving ibuprofen containing compositions having analgesic activity
11/27/2007CA2309380C Viscous compositions containing carbon dioxide
11/27/2007CA2306883C Fast-dissolving pharmaceutical composition comprising as-3201
11/27/2007CA2301174C A method for inducing therapeutically-effective proteins
11/27/2007CA2271683C Coated particles, methods of making and using
11/27/2007CA2267932C Compositions for postgastrectomic mineral supply
11/22/2007WO2007134245A2 Elastin-like polymer delivery vehicles
11/22/2007WO2007133902A2 Adaptive rate and reach optimization for wireless access networks
11/22/2007WO2007133807A2 Polymers for functional particles
11/22/2007WO2007133642A1 Sport drink containing amino acids and carbohydrates
11/22/2007WO2007133627A2 Method for making liposomes conjugated with temperature-sensitive ligands
11/22/2007WO2007133508A1 Water dispersible films for delivery of active agents to the epidermis
11/22/2007WO2007133218A1 Methods and compositions relating to animal dietary acids
11/22/2007WO2007133141A1 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007WO2007133140A1 Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007WO2007132956A1 Polyethylene glycol-interferon alpha conjugate
1 ... 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 ... 1712